Accelerating Chemical Biology and early Drug Discovery by academic collaborative initiatives
-
Chair(s):
Dr Bahne Stechmann, Head of Operations & Scientific Strategy, EU-OPENSCREEN, Berlin, Germany
-
Session description:
EU-OPENSCREEN - An open-access research infrastructure for chemical biology and early drug discovery
Dr Bahne Stechmann
Head of Operations & Scientific Strategy, EU-OPENSCREEN, Berlin, GermanySourcing of compounds from the chemistry community as a model to expose them to new targets
Professor Päivi Tammela
Professor at the Faculty of Pharmacy & Head of the FIMM High Throughput Biomedicine Unit, University of Helsinki, Helsinki, FinlandThe Kærtor Foundation - A Galician initiative in open-innovation and public-private co-development in drug discovery
Professor Mabel Loza
Professor of Pharmacology & Coordinator of BioFarma Research Group, University of Santiago de Compostela, Santiago de Compostela, SpainSmall molecule inhibitors of the production of reactive oxygen species
Dr Ctibor Skuta
Head of the cheminformatics & software development unit, Institute of Molecular Genetics of the ASCR, Czech RepublicDistributed, Open Chemistry Towards New Medicines on a Planetary Scale
Professor Matthew Todd
Professor of Drug Discovery, UCL School of Pharmacy, London, United Kingdom
Speakers
-
Dr Bahne StechmannHead of Operations & Scientific Strategy,EU-OPENSCREEN, Berlin, Germany
-
Dr Ctibor SkutaHead of the cheminformatics & software development unit, Institute of Molecular Genetics of the ASCR, Czech Republic
-
Professor Mabel LozaProfessor of Pharmacology & Coordinator of BioFarma Research Group,University of Santiago de Compostela, Santiago de Compostela, Spain
-
Professor Matthew ToddProfessor of Drug Discovery, UCL School of Pharmacy, London, United Kingdom
-
Professor Päivi TammelaProfessor at the Faculty of Pharmacy & Head of the FIMM High Throughput Biomedicine Unit,University of Helsinki, Helsinki, Finland